Home LiteratureArticle Details
PMID: 17181866 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Effects of the diabetes linked TCF7L2 polymorphism in a representative older population.

BMC medicine ·Vol. 4 ·2006-12-20 ·Pages 34

Melzer D, Murray A, Hurst AJ, Weedon MN, Bandinelli S, Corsi AM, Ferrucci L, Paolisso G, Guralnik JM, Frayling TM

Abstract

A polymorphism in the transcription factor 7-like 2 (TCF7L2) gene has been found to be associated with type 2 diabetes in case-control studies. We aimed to estimate associations of the marker rs7903146 (C/T) polymorphism with fasting glucose, lipids, diabetes prevalence and complications in an older general population. In total, 944 subjects aged > or = 65 years from the population representative InCHIANTI study were enrolled in this study. Those with fasting blood glucose of > or = 7 mmol/l or physician diagnosis were considered diabetic. Cut-off points for impaired fasting glucose (IFG) were > or = 5.6 mmol/l to < 7 mmol/l. In the general population sample, minor (T) allele carriers of rs7903146 had higher fasting blood glucose (FBG) (p = 0.028) but lower fasting insulin (p = 0.030) and HOMA2b scores (p = 0.001), suggesting poorer beta-cell function. T allele carriers also had smaller waist circumference (p = 0.009), lower triglyceride levels (p = 0.006), and higher high-density lipoprotein cholesterol (p = 0.008). The prevalence of diabetes or IFG was 32.4% in TT carriers and 23.3% in CC carriers; adjusted OR = 1.67 (95% confidence interval 1.05 to 2.65, p = 0.031). Within the diabetic and IFG groups, fewer T allele carriers had metabolic syndrome features (p = 0.047) or had experienced a myocardial infarction (p = 0.037). Conversely, T allele carriers with diabetes had poorer renal function (reduced 24-hour creatinine clearance, p = 0.013), and possibly more retinopathy (p = 0.067). Physician-diagnosed dementia was more common in the T carriers (in diabetes p = 0.05, with IFG p = 0.024). The TCF7L2 rs7903146 polymorphism is associated with lower insulin levels, smaller waist circumference, and lower risk lipid profiles in the general elderly population. Patients with diabetes who are carriers of the minor allele are less likely to have metabolic-syndrome features, but may experience more microvascular complications, although the number of cases was small. If replicated, these findings may have implications for developing treatment approaches tailored by genotype.

MeSH Terms
Aged Aged, 80 and over Aging/genetics Body Size Cohort Studies Diabetes Mellitus/genetics Female Humans Insulin/blood Italy Lipids/blood Male Polymorphism, Genetic TCF Transcription Factors/genetics Transcription Factor 7-Like 2 Protein
Chemicals
Insulin Lipids TCF Transcription Factors TCF7L2 protein, human Transcription Factor 7-Like 2 Protein
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Melzer David
Peninsula Medical School, RD&E Wonford Site, Barrack Road, Exeter, EX2 5DW, UK. [email protected]
Murray Anna
Hurst Alison J
Weedon Michael N
Bandinelli Stefania
Corsi Anna Maria
Ferrucci Luigi
Paolisso Guiseppe
Guralnik Jack M
Frayling Timothy M
References (29)
29 references, click to expand
  1. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.
    J Am Geriatr Soc. 2000 Dec;48(12):1618-25 PMID: 11129752
  2. High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study.
    Atherosclerosis. 2007 Jun;192(2):384-90 PMID: 16787648
  3. Glucose tolerance, glucose utilization and insulin secretion in ageing.
    Novartis Found Symp. 2002;242:222-42; discussion 242-6 PMID: 11855690
  4. The architecture of diagnostic research.
    BMJ. 2002 Mar 2;324(7336):539-41 PMID: 11872558
  5. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
    JAMA. 2002 May 15;287(19):2570-81 PMID: 12020339
  6. Molecular understanding of hyperglycemia's adverse effects for diabetic complications.
    JAMA. 2002 Nov 27;288(20):2579-88 PMID: 12444865
  7. Perspectives on diabetic retinopathy.
    Am J Ophthalmol. 2003 Jul;136(1):122-35 PMID: 12834680
  8. Follow-up report on the diagnosis of diabetes mellitus.
    Diabetes Care. 2003 Nov;26(11):3160-7 PMID: 14578255
  9. Biochemical pathways for microvascular complications of diabetes mellitus.
    Ann Pharmacother. 2003 Dec;37(12):1858-66 PMID: 14632543
  10. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
    Diabetes Care. 1997 Jul;20(7):1183-97 PMID: 9203460
  11. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
    BMJ. 1998 Mar 14;316(7134):823-8 PMID: 9549452
  12. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet. 1998 Sep 12;352(9131):837-53 PMID: 9742976
  13. The effect of diabetes on disability in middle-aged and older adults.
    J Gerontol A Biol Sci Med Sci. 2005 Sep;60(9):1206-11 PMID: 16183964
  14. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study.
    Arch Intern Med. 2005 Oct 24;165(19):2222-7 PMID: 16246987
  15. Proinflammatory state and circulating erythropoietin in persons with and without anemia.
    Am J Med. 2005 Nov;118(11):1288 PMID: 16271918
  16. Risk of dementia in diabetes mellitus: a systematic review.
    Lancet Neurol. 2006 Jan;5(1):64-74 PMID: 16361024
  17. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
    Nat Genet. 2006 Mar;38(3):320-3 PMID: 16415884
  18. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.
    BMJ. 2006 May 13;332(7550):1115-24 PMID: 16585050
  19. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes.
    Endocrinology. 2006 Jun;147(6):2657-63 PMID: 16556760
  20. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.
    Int J Cardiol. 2006 Jun 16;110(2):137-45 PMID: 16289373
  21. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
    N Engl J Med. 2006 Jul 20;355(3):241-50 PMID: 16855264
  22. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk.
    Diabetes. 2006 Sep;55(9):2640-4 PMID: 16936215
  23. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men.
    Diabetes. 2006 Sep;55(9):2645-8 PMID: 16936216
  24. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample.
    Diabetes. 2006 Sep;55(9):2649-53 PMID: 16936217
  25. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.
    Diabetes. 2006 Sep;55(9):2654-9 PMID: 16936218
  26. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
    Diabetes. 2006 Oct;55(10):2890-5 PMID: 17003358
  27. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
    Diabetes. 2006 Oct;55(10):2903-8 PMID: 17003360
  28. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction.
    PLoS Med. 2006 Oct;3(10):e374 PMID: 17020404
  29. Pathogenesis of diabetic nephropathy.
    Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S424-37 PMID: 11460589
Article Info
Journal
BMC medicine
Abbr.
BMC Med
ISSN
1741-7015
Published
2006-12-20
Epub
2006-00-20
Pages
34
Language
English
Region
England
NLM ID
101190723
PMCID
PMC1769391
Subset
IM
Grants
NIA NIH HHS · R01 AG024233 · United States
NIA NIH HHS · R01 AG24233-01 · United States
Intramural NIH HHS · Z99 AG999999 · United States
NIA NIH HHS · N01-AG-821336 · United States
NIMHD NIH HHS · 263 MD 9164 13 · United States
NIMHD NIH HHS · R01 MD009164 · United States
NIA NIH HHS · N01-AG-916413 · United States
NIMHD NIH HHS · 263 MD 821336 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]